{"id":"W3170806165","doi":"10.1200/jco.2021.39.15_suppl.5037","title":"Analysis of two poor prognosis subgroups in ACIS evaluating apalutamide + abiraterone acetate plus prednisone (APA + AAP) versus placebo (PBO) + AAP in metastatic castration-resistant prostate cancer (mCRPC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Janssen Research and Development","keywords":"Medicine; Abiraterone acetate; Prostate cancer; Internal medicine; Clinical endpoint; Placebo; Prednisone; Progression-free survival; Adverse effect; Population; Randomization; Enzalutamide; Randomized controlled trial; Urology; Gastroenterology; Oncology; Surgery; Cancer; Chemotherapy; Androgen deprivation therapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002532131,0.0007085159,0.001847,0.0004125212,0.0002689935,0.0007216343,0.0004721996,0.0007493686,0.002217559],"category_scores_gemma":[0.00239364,0.00030433,0.001747237,0.0003721809,0.0005579267,0.0005045626,0.0004757938,0.001129068,0.0002926909],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005858643,"about_ca_system_score_gemma":0.000882157,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000532969,"about_ca_topic_score_gemma":0.0008568228,"domain_scores_codex":[0.9986898,0.0007401497,0.0001009021,0.0002126894,0.0001223486,0.0001340479],"domain_scores_gemma":[0.9980533,0.0007099744,0.0004724846,0.0001301923,0.00008933496,0.0005447224],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9636437,0.002723726,0.01409628,0.0001545496,0.001188957,0.00003807715,0.00005648735,0.000428297,0.004533254,0.00005453701,0.0001499488,0.01293234],"study_design_scores_gemma":[0.2945763,0.5136702,0.1764722,0.0000703011,0.005079044,0.0002016224,0.0002057887,0.004186884,0.003620765,0.0005659218,0.001293918,0.00005704765],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981222,0.000700692,0.0002136456,0.00006369305,0.00003114994,0.0003754192,0.0001658507,0.000008095802,0.0003193344],"genre_scores_gemma":[0.9983688,0.0001933707,0.0003152859,0.00008812034,0.000055369,0.0004511821,0.0003424459,0.000002396232,0.0001831534],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002532131,"threshold_uncertainty_score":0.01339132,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2459859785476894,"score_gpt":0.5368218909530965,"score_spread":0.2908359124054071,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}